Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,418
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Location: Seattle WA, Vancouver, Portland OR, San Francisco CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
for
B-cell Malignancies
Location: Seattle WA, Calgary, La Jolla CA, Rochester MN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06542250
Phase1, Phase2, Recruiting
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18 - 40
Code: NCT00504413
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Seattle WA, Abbotsford British Columbia, Burnaby,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Seattle WA, Tacoma WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
for
High-Risk Prostate Cancer
Location: Seattle WA, Portland OR, West Los Angeles CA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05593497
Phase2, Recruiting
New
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
for
Human Papilloma Virus (HPV),
Location: Seattle WA, Layton UT, Phoenix AZ, Little Rock AR
Sponsor: Daré Bioscience, Inc.
Sex: Female
Age: 22 - 50
Code: NCT07601074
Phase2, Recruiting
New
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
for
Congenital Adrenal Hyperplasia
Location: Seattle WA, San Francisco CA, Philadelphia PA,
Sponsor: Neurocrine Switzerland GmbH
Sex: All
Age: 0 - 3
Code: NCT07536269
Phase2, Recruiting
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data